Abstract

In obstetric practice, the search for reserves to increase the effectiveness of prevention of gestational complications associated with infectious and inflammatory diseases of the urinaiy system is relevant. The purpose of this study was to assess the results of using the Canephron® N herbal medicine in pregnant women with chronic pyelonephritis. The study included 100 women, randomly divided into four groups, three of which were carried out for prophylactic use of the drug Canephron®N, and were not prescribed phytoprophylaxis in the fourth. It has been established that monotherapy with Canephron®N reduces the risk of exacerbations of chronic pyelonephritis, improves the functional state of the urinary tract, reduces the incidence of bacteriuria. Optimal results are achieved with the use of prophylactic courses of Canephron®N at the gestational period of 10-12, 22-24, and 34-36 weeks.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call